When was Megsan Labs founded?

Megsan Labs was founded in 2014.

Where is Megsan Labs located?

Megsan Labs is headquartered in Hyderabad, India.

How many employees does Megsan Labs have?

As of Apr 30, 2026, the latest employee count at Megsan Labs is 200.

Is Megsan Labs a funded company?

Megsan Labs is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Megsan Labs rank among its competitors?

Megsan Labs ranks 35th amongst 806 active competitors, of which 54 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Alloy Therapeutics, which secured $40M in Mar, 2026.

Who are the top competitors of Megsan Labs?

Megsan Labs' top competitors include Alloy Therapeutics, Maiva Pharma and Simulations Plus. Among them, Alloy Therapeutics secured the most recent funding round in March, 2026.

Megsan Labs - 2026 Company Profile, Competitors & Financials

Megsan Labs is an acquired company based in Hyderabad (India), founded in 2014. It operates as a Provider of analytical laboratory testing services for pharmaceutical and packaging industries. The company has 806 active competitors, including 54 funded and 47 that have exited. Its top competitors include companies like Alloy Therapeutics, Maiva Pharma and Simulations Plus.

Company Details

Provider of analytical laboratory testing services for pharmaceutical and packaging industries. The organization performs analytical tests ensuring materials and products meet quality and regulatory standards. Services include elemental impurity studies, extractable and leachable studies, and genotoxic impurity studies. Additional services cover method development, validation, and stability studies.

Website: megsanlabs.com
Email ID: *****@megsanlabs.com
Phone Number: +91 **********

Key Metrics

Founded Year

2014

Location

Hyderabad, India

Stage

Acquired

Ranked

35^th among 806 active competitors

Employee Count

200 as on Apr 30, 2026

Similar Companies

Alloy Therapeutics & 827 more

Exit Details

Acquired by Tentamus (Jun 24, 2019)

View Megsan Labs' full profile

Megsan Labs is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Tentamus Analytics GmbH CIN: HRB140314 , Germany, Active	Jul 27, 2011	$203M (As on Dec 31, 2020)	-

Megsan Labs got acquired by Tentamus on Jun 24, 2019.

Click here to take a look at Megsan Labs's acquisition in detail

Megsan Labs has not raised any funding rounds yet.

Megsan Labs' employee count trend

Megsan Labs has 200 employees as of Apr 26. Here is Megsan Labs's employee count trend over the years:

Uncover Megsan Labs' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Megsan Labs include Alloy Therapeutics, Maiva Pharma and Simulations Plus. Here is the list of Top 10 competitors of Megsan Labs, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Alloy Therapeutics 2017, Lexington (United States), Series E	Provider of drug discovery services	$157M	8VC, Mubadala & 11 others	63/100
2nd	Maiva Pharma 1996, Hosur (India), Late Stage	Manufacturer of sterile injectables	$125M	Nhpea V Spear, Nano-Vista & 25 others	61/100
3rd	Simulations Plus 1996, Lancaster (United States), Public	Developer of modeling and simulation software and consulting services provider	-	FDA, NIH & 1 others	60/100
4th	Manifold Bio 2018, United States, Series A	Developer of tissue-targeted therapeutics using in vivo screening and AI design	$78.2M	Playground Global, Triatomic & 8 others	58/100
5th	VelaVigo 2021, Shanghai (China), Seed	Biotechnology research company developing biological drugs	$160M	Shunwei Capital, Panacea Venture & 17 others	54/100
6th	CILcare 2014, Montpellier (France), Series A	Service to develop health products aiming to diagnose, prevent, delay the progression or treat hearing loss and tinnitus	$42.3M	Shionogi, UVM Health & 4 others	53/100
7th	Biocom California 1995, San Diego (United States), Acquired	CRO focused on drug discovery & development for multiple therapeutic areas	-	-	51/100
8th	Syenex 2022, Chicago (United States), Series B	Developer of cell-specific delivery systems and programmable cell engineering payloads	$13.7M	AlleyCorp, KdT Ventures	51/100
9th	Viva Biotech 2006, Shanghai (China), Public	Research services focused on drug discovery and development	-	Temasek, ShenZhen GTJA Investment Group & 3 others	51/100
10th	Superluminal Medicines 2022, Boston (United States), Series A	Generative biological and chemical company focused on drug discovery	$158M	RA Capital Management, Insight Partners & 5 others	50/100
35th	Megsan Labs 2014, Hyderabad (India), Acquired	Provider of analytical laboratory testing services for pharmaceutical and packaging industries	-	-	34/100